Terms: = Bone cancer AND NTRK3, TRKC, 4916, ENSG00000140538, Q16288, gp145 trkC AND Diagnosis
6 results:
1. Detection of Novel Tyrosine Kinase Fusion Genes as Potential Therapeutic Targets in bone and Soft Tissue Sarcomas Using DNA/RNA-based Clinical Sequencing.
Hasegawa N; Hayashi T; Niizuma H; Kikuta K; Imanishi J; Endo M; Ikeuchi H; Sasa K; Sano K; Hirabayashi K; Takagi T; Ishijima M; Kato S; Kohsaka S; Saito T; Suehara Y
Clin Orthop Relat Res; 2024 Mar; 482(3):549-563. PubMed ID: 38014853
[TBL] [Abstract] [Full Text] [Related]
2. Cytologic, histologic, and molecular features of pancreatic sarcomatoid undifferentiated carcinoma with heterologous osteosarcomatous transformation.
Zhang ML; Sabatino ME; Castillo CF; Mattia AR; Chebib I
Diagn Cytopathol; 2023 May; 51(5):E164-E169. PubMed ID: 36762822
[TBL] [Abstract] [Full Text] [Related]
3. Primary NTRK-rearranged spindle cell neoplasm of bone harboring an HMBOX1::ntrk3 gene fusion.
Wang Z; Wang J
Genes Chromosomes Cancer; 2023 Aug; 62(8):477-482. PubMed ID: 36740981
[TBL] [Abstract] [Full Text] [Related]
4. A novel TMTC2-ntrk3 fusion in undifferentiated high-grade pleomorphic sarcoma.
Bai C; Zhang L; Wang Y; You X; Ju Y; Sun T; Fan Z
J Cancer Res Clin Oncol; 2022 Oct; 148(10):2933-2937. PubMed ID: 35933643
[TBL] [Abstract] [Full Text] [Related]
5. NTRK Fusions Detection in Paediatric Sarcomas to Expand the Morphological Spectrum and Clinical Relevance of Selected Entities.
Nozzoli F; Lazar AJ; Castiglione F; Campanacci DA; Beltrami G; De Logu F; Caporalini C; Massi D; Roviello G
Pathol Oncol Res; 2022; 28():1610237. PubMed ID: 35295613
[TBL] [Abstract] [Full Text] [Related]
6. Expanding the Molecular Genetic Spectrum of bone and Soft Tissue Fibrosarcomas: An Institutional Experience.
Leckey BD; John I; Wald A; Naous R
Int J Surg Pathol; 2022 Apr; 30(2):145-150. PubMed ID: 34382874
[No Abstract] [Full Text] [Related]
